| Primary |
| Multiple Sclerosis |
100.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
64.8% |
| Premedication |
8.4% |
| Metastases To Peritoneum |
3.3% |
| Chronic Lymphocytic Leukaemia |
2.6% |
| Multiple Sclerosis |
2.2% |
| Bronchial Disorder |
1.8% |
| Chemotherapy |
1.8% |
| Prophylaxis |
1.8% |
| Aplasia |
1.6% |
| Sciatica |
1.6% |
| Hypertension |
1.5% |
| Encephalitis |
1.1% |
| Escherichia Infection |
1.1% |
| Pancreatic Carcinoma |
1.1% |
| Acute Lymphocytic Leukaemia |
0.9% |
| Crohn's Disease |
0.9% |
| Interstitial Lung Disease |
0.9% |
| Lupus Nephritis |
0.9% |
| Mantle Cell Lymphoma |
0.9% |
| B-cell Lymphoma |
0.7% |
|
| Toxic Epidermal Necrolysis |
19.0% |
| Vomiting |
9.5% |
| Skin Plaque |
7.1% |
| Tachycardia |
7.1% |
| Weight Increased |
7.1% |
| Epistaxis |
4.8% |
| Pseudomonas Infection |
4.8% |
| Pyrexia |
4.8% |
| Renal Tubular Disorder |
4.8% |
| Treatment Failure |
4.8% |
| Visual Impairment |
4.8% |
| Affective Disorder |
2.4% |
| Breast Cancer |
2.4% |
| Cardiac Failure |
2.4% |
| Cardiomegaly |
2.4% |
| Death |
2.4% |
| Device Related Infection |
2.4% |
| Disease Recurrence |
2.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.4% |
| Dyspnoea |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.3% |
| Multiple Sclerosis |
12.7% |
| Premedication |
12.0% |
| Gout |
4.2% |
| Pain |
3.8% |
| Prophylaxis |
3.8% |
| Drug Use For Unknown Indication |
3.5% |
| Hypertension |
3.5% |
| Multiple Sclerosis Relapse |
3.0% |
| Renal Transplant |
3.0% |
| Adverse Event |
2.9% |
| Colon Cancer |
2.8% |
| Crohn's Disease |
2.6% |
| Immunosuppression |
2.4% |
| Gestational Trophoblastic Tumour |
1.8% |
| Allergy Prophylaxis |
1.7% |
| Chronic Lymphocytic Leukaemia |
1.7% |
| Systemic Lupus Erythematosus |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Breast Cancer Metastatic |
1.3% |
|
| Vomiting |
10.1% |
| Infusion Related Reaction |
7.9% |
| Progressive Multifocal Leukoencephalopathy |
7.2% |
| Pyrexia |
6.5% |
| Thrombocytopenia |
5.8% |
| Urticaria |
5.8% |
| Renal Impairment |
5.0% |
| Sepsis |
5.0% |
| Pseudomembranous Colitis |
4.3% |
| Pulmonary Embolism |
4.3% |
| Rash |
4.3% |
| Urinary Tract Infection |
4.3% |
| Weight Decreased |
4.3% |
| Nausea |
3.6% |
| Pain |
3.6% |
| Paraesthesia |
3.6% |
| Renal Failure |
3.6% |
| Renal Failure Acute |
3.6% |
| Respiratory Failure |
3.6% |
| Therapeutic Response Decreased |
3.6% |
|
